Literature DB >> 20141676

NCCN clinical practice guidelines in oncology: prostate cancer.

James Mohler, Robert R Bahnson, Barry Boston, J Erik Busby, Anthony D'Amico, James A Eastham, Charles A Enke, Daniel George, Eric Mark Horwitz, Robert P Huben, Philip Kantoff, Mark Kawachi, Michael Kuettel, Paul H Lange, Gary Macvicar, Elizabeth R Plimack, Julio M Pow-Sang, Mack Roach, Eric Rohren, Bruce J Roth, Dennis C Shrieve, Matthew R Smith, Sandy Srinivas, Przemyslaw Twardowski, Patrick C Walsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20141676     DOI： 10.6004/jnccn.2010.0012

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  247 in total

Review 1.  Management of low (favourable)-risk prostate cancer.

Authors:  H Ballentine Carter
Journal:  BJU Int       Date:  2011-12       Impact factor: 5.588

Review 2.  Active surveillance for low-risk prostate cancer: an update.

Authors:  Nathan Lawrentschuk; Laurence Klotz
Journal:  Nat Rev Urol       Date:  2011-04-26       Impact factor: 14.432

3.  Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: a single institution experience.

Authors:  Minoru Kobayashi; Akinori Nukui; Kazumi Suzuki; Shinsuke Kurokawa; Tatsuo Morita
Journal:  Int J Clin Oncol       Date:  2011-04-23       Impact factor: 3.402

4.  HIFU ablation is not a proven standard treatment for localized prostate cancer.

Authors:  Alan I So
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

5.  High-risk prostate cancer: is androgen deprivation monotherapy still appropriate?

Authors:  Vahakn B Shahinian
Journal:  Asian J Androl       Date:  2012-02-06       Impact factor: 3.285

Review 6.  Pictorial review. Magnetic resonance for radiotherapy management and treatment planning in prostatic carcinoma.

Authors:  Christopher Lim; Shawn C Malone; Leonard Avruch; Rodney H Breau; Trevor A Flood; Megan Lim; Christopher Morash; Jeff S Quon; Cynthia Walsh; Nicola Schieda
Journal:  Br J Radiol       Date:  2015-08-17       Impact factor: 3.039

7.  Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.

Authors:  A Gómez Caamaño; A Zapatero; J López Torrecilla; X Maldonado
Journal:  Clin Transl Oncol       Date:  2015-11-30       Impact factor: 3.405

8.  Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.

Authors:  Jose López-Torrecilla; Anna Boladeras; María Angeles Cabeza; Almudena Zapatero; Josep Jove; Luis M Esteban; Ivan Henriquez; Manuel Casaña; Carmen González-San Segundo; Antonio Gómez-Caamaño; Jose Luis Mengual; Asunción Hervás; Julia Luisa Muñoz; Gerardo Sanz
Journal:  Strahlenther Onkol       Date:  2015-07-09       Impact factor: 3.621

9.  Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.

Authors:  Daniel M Frendl; Mara M Epstein; Hassan Fouayzi; Richard Krajenta; Benjamin A Rybicki; Mitchell H Sokoloff
Journal:  Cancer Causes Control       Date:  2020-06-17       Impact factor: 2.506

10.  Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.

Authors:  Amy N Luckenbaugh; Gregory B Auffenberg; Scott R Hawken; Apoorv Dhir; Susan Linsell; Sanjeev Kaul; David C Miller
Journal:  J Urol       Date:  2016-09-20       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.